DEF 14C

DEFINITIVE INFORMATION STATEMENT

Company: Silo Pharma, Inc.
Filed: June 5, 2017
Period of Report: June 5, 2017
Accession Number: 0001213900-17-006156

View Document ↗ View on SEC.gov ↗